JP
Jasmina Prem Aildasani
About Jasmina Prem Aildasani
Jasmina Prem Aildasani has 23 years in corporate governance. Holds Director role. Currently with 2 companies, including Balaji Steroids And Hormones Private Limited and Broadway Pharmaceuticals Private Limited. Formerly with 2 companies, such as Betabiopharm Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Balaji Steroids And Hormones Private Limited
U24230MP2010PTC023386
|
Director | 23 Mar 2019 | 2010 | Active |
Broadway Pharmaceuticals Private Limited
U51909MP2022PTC063057
|
Director | 12 Oct 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Betabiopharm Private Limited
U51909GJ2022PTC135997
|
Director | 07 Oct 2022 | 2022 | Active |
|
Jahan Impex Private Limited
U52310MH2003PTC139992
|
Director | 10 Apr 2003 | 2003 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jasmina Prem Aildasani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jasmina Prem Aildasani
Jasmina Prem Aildasani has 23 years in corporate governance. Holds Director role. Currently with 2 companies, including Balaji Steroids And Hormones Private Limited and Broadway Pharmaceuticals Private Limited. Formerly with 2 companies, such as Betabiopharm Private Limited. Engaged in General Business. Contributes to corporate operations.
Jasmina Prem Aildasani is associated with 2 companies as Director.
Jasmina Prem Aildasani has expertise in General Business.
Jasmina Prem Aildasani has 23 years in corporate governance.